Effects of potassium channel openers on Na+ and K+ currents in rabbit sinus node and atrial myocytes  by Tromba, Cinzia & Cohen, Ira S.
ELSEVIER Biochimica et Biophysica Acta 1266 (1995) 268-272 
BB 
Biochi~ic~a et Biophysica A~ta 
Rapid Report 
Effects of potassium channel openers on Na + and K + currents in rabbit 
sinus node and atrial myocytes 
Cinzia Tromba, Ira S. Cohen * 
Department of Physiology and Biophysics, Health Sciences Center, SUNY, Stony Brook, NY 11794-8661, USA 
Received 13 January 1995; accepted 23 February 1995 
Abstract 
The effects of the potassium channel openers (KCOs) Cromakalim and Lemakalim on rabbit sinoatrial and atrial myocytes were 
examined by means of the whole-cell patch-clamp technique. Lemakalim (up to 100/xM) had no effect on potassium current in sinoatrial 
cells. Both Lemakalim and Cromakalim (100 /xM) displayed a two-fold action on atrial myocytes: (1) they increased an outwardly 
rectifying conductance at potentials positive to E K and, (2) they markedly decreased a TTX-sensitive Na + current active in the voltage 
range -50 / -  30 inV. This novel action on TTX-sensitive currents is of particular interest since these two benzopyrans have been 
thought o specifically target potassium channels. 
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KAT P channels were first described by Noma [1] in 
guinea pig ventricular myocytes as channels regulated by 
intracellular ATP, being inhibited at physiological concen- 
trations of the nucleotide and activated whenever its con- 
centration diminishes below a certain threshold. Since 
Noma's first report, K + channels inhibited by ATP i have 
been discovered in a variety of tissues (pancreas, skeletal 
and smooth muscle, neurons, etc.) where they have been 
shown to play roles and to assume characteristics that vary 
depending on the tissue of origin (for a review see Ashcroft 
and Ashcroft [2]). In the heart, for example, the opening of 
KAT P channels is thought o induce the shortening of the 
action potential that is typical of ischemic myocytes, and it 
has been hypothesized that they may act as a safety 
mechanism during ischemic episodes, by lowering the 
myocytes metabolic demand. 
KAT P channels eem to constitute a heterogeneous fam- 
ily, endowed with a distinctive pharmacology: drugs known 
as sulphonylureas (i.e., Glibenclamide) are specific in- 
hibitors of the channels' activity, while compounds belong- 
ing to the inhomogenous class of the potassium channel 
openers (KCOs) such as Cromakalim and its active enan- 
tiomer, Lemakalim, act as potent activators. 
The great majority of the in vitro studies concerned 
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with cardiac KAT P channels have been conducted in ven- 
tricular myocytes. Although functionally the diverse areas 
of the heart play very different roles, only sparse reports 
exist on the properties of such channels in other types of 
cardiac muscle. Among these, Kakei and Noma [3] proved 
the existence of KAT P channels in the atrio-ventricular 
node of rabbit heart; in guinea pig atrial cells, Hamada et 
al. [4] have demonstrated that a K + current elicited by the 
KCO Nicorandil was specifically blocked by Gliben- 
clamide; furthermore, contradictory reports on rabbit sino- 
atrial node myocytes by Satoh [5] and Satoh and Hashimoto 
[6] supported the idea that, while not able to specifically 
activate KAT P channels, diverse KCOs affected instead 
different currents, such as I~i of I k. 
We conducted this study with the aim of looking for the 
presence of KAT P channels in different regions of the heart 
obtained from a single species, i.e., the rabbit. We used 
Cromakalim and Lemakalim to activate the channels and 
Glibenclamide as a tool to assess the identity of the 
channels activated by the KCOs. 
SA, atrial and ventricular cells were all isolated from 
rabbit (2-3 kg) hearts by enzymatic dissociation. Briefly, 
after the animals were injected with a euthanasia dose of 
sodium pentobarbitone (100 mg/kg), the hearts were 
quickly removed and placed in warm Tyrode's solution 
containing heparin (4 U/ml).  Then, slightly different pro- 
cedures were applied depending on the type of cells to be 
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obtained. SA myocytes: the SA node was quickly isolated 
from the right atrium, placed in a bath perfused with 
Tyrode's solution at 37 ° (2, cut in strips perpendicular to 
the crista terminalis and hfft to recover spontaneous activ- 
ity. The strips were then cut free from the the crista 
terminalis and rinsed for 5 min in a Ca2+-free solution of 
the following composition (in mM): NaC1 140, KCI 5.4, 
MgSO 4 0.5, Hepes-NaOH 5, Dextrose 10.0 (pH 6.9). After 
this period CaC12 (0.05 mM), Albumin (1 mg/ml,  Sigma, 
USA), Collagenase (280 U/ml ,  Cls II, Worthington, USA) 
and Elastase (30 U/ml ,  Type I, Sigma, USA) were added 
to the Ca2+-free solution and the strips shaken for 5-10 
min. The tissue was subsequently transferred into a KB- 
modified solution of the following composition (in mM): 
KC1 70, KH2PO 4 20, MgSO 4 5, K-glutamic acid 5, suc- 
cinic acid 5, trisphosphocreatine 5, K2ATP 5, K-EGTA 
0.04, Taurine 20, Hepes-KOH 5, Dextrose 10, Albumin (1 
mg/ml)  (pH 6.9) where the cells were actually separated 
and then stored, after being filtered through a nylon mesh. 
Atrial myocytes: the left atrium was rapidly removed from 
the heart and cut into pieces. The dissociation procedure 
was then the same as for SA cells, except hat elastase was 
in this case used at a concentration of 10 U/ml .  
Once in the experimental bath, the cells were super- 
fused with normal Tyrode's solution (in mM): NaC1 140, 
KC1 5.4, CaC12 1.8, MgC12 1.0, Hepes-KOH 5, Dextrose 
10.0 (pH 7.35), at a rate of 2 ml /min and at a temperature 
of 32 ° C. The whole-cell configuration of the patch-clamp 
recording technique was used in all experiments. The 
pipettes had a resistance of 3-7 M O, depending on the 
type of cells studied, and were filled with a solution 
containing (in mM): K-aspartate 130, NaC1 10, EGTA- 
KOH 0.1, Mg-ATP 2, Na-GTP 0.1, Hepes-KOH 10. We 
did not compensate for series resistances, o the maximum 
voltage error, considering a 7 M O pipette and a current of 
500 pA, would amount to 3.5 mV. Cromakalim and 
Glibenclamide were purchased from Sigma (USA), while 
Lemakalim was a gift from SmithKline Beecham (UK). 
Concentrated stock solutions of all the drugs were made in 
DMSO and then diluted (_> 1:1000) in bathing solution. 
The data were stored by means of a VCR employing a 
PCM converter system (VR-10, Instrutech, NY), and then 
analyzed with P-CLAMP (Axon Instruments, USA). 
Sinus node. In order to investigate the possibility that 
potassium channels of the type opened by KCOs (com- 
monly known as KAT P channels) were present in pace- 
maker cells of the sino-atrial node, we tested the effect of 
Lemakalim, the active emmtiomer of Cromakalim, by ap- 
plying fast voltage ramps (1 mV/ms)  spanning from 
-120  to + 30 mV membrane potential. Under these ex- 
perimental conditions the current/voltage r lationship in 
nodal cells is almost linear. We chose voltage ramps over 
voltage pulses because we were interested in studying the 
possible activation of a K current, the one flowing through 
KAT P channels, known to develop in a time-independent 
fashion, while avoiding the overlapping activation of 
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Fig. 1. Lemakalim does not affect he I/V relationship in sino-atrial 
pacemaker myocytes. (A) typical current responses to hyperpolarizing 
steps of pace-maker cells. The cell was held at -35 mV; consecutive 
hyperpolarizing steps were applied from -60 to -110 mV at 10-mV 
intervals. The predominant current developing atthese potentials is if. (B) 
Same cell as in (A). Current response toa voltage ramp spanning from 
-125 to +25 mV membrane potential. The two curves obtained in
control and in the presence ofLemakalim 100 /zM are superimposed. 
time-dependent currents, one of which, if, is very promi- 
nent in these cells at hyperpolarized potentials. The cells 
chosen for this study were only the ones with the morphol- 
ogy and the if current typical of the real pace-maker type 
(Fig. 1A). 
An example of the I /V  curves obtained before and after 
the application of a maximal dose of Lemakalim (100 
/.tM) is shown in Fig. lB. Consistent with a previous 
report [5], sino-atrial node pacemaker myocytes did not 
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respond to the application of Lemakalim with an increased 
potassium conductance. The I /V  relationship, as obtained 
in these experimental conditions, appeared totally unaf- 
fected by the drug. Similar results were obtained in a total 
of 15 out of 15 cells studied. 
Some myocytes isolated from the sinus node, possibly 
belonging to the transitional type, showed slightly different 
characteristics, such as larger cell's size, a less prominent 
if and a less ohmic I /V  relationship. In these cells expo- 
sure to Lemakalim induced a decrease in an unidentified 
inward current similar to that reported below for atrial 
myocytes and a slight increase in the outward current (not 
shown). 
Atrial myocytes. Atrial myocytes had more instanta- 
neous current and a much smaller if in response to step 
hyperpolarizations (Fig. 2A). Basically the same protocol 
was employed for atrial myocytes, but in this case the 
shape of the I /V  relationship was different. In atrial cells 
in fact, the I /V  relationship was not linear, since a large 
inward current was usually detected in the voltage range 
-50 / -  30 mV. Occasionally, another, smaller inward 
current was visible in the voltage range -20 /0  mV. 
Fig. 2B shows an example of the results obtained in this 
set of experiments. In contrast o sinus node cells, atrial 
myocytes did respond to the application of KCOs. The 
effect induced by both, Cromakalim and Lemakalim, was, 
however, two-fold. The most surprising and consistent (it 
was found in > 90% of the cells tested) finding was a 
dramatic reduction of the inward current developing in the 
voltage range -50 / -  30 mV. The second, somewhat less 
reproducible (it was detected in only 20 out of 34 cells) 
effect was a pronounced increase of an outward conduc- 
tance, which is consistent with the drugs acting as potas- 
sium channels activators. That this outward current was 
indeed carrying K ÷ ions was supported by experiments 
with BaC12, Ba 2÷, a potent K channel blocker, when 
added to the control solution at a concentration of 5 
mM/1 was able to readily block the drug-induced increase 
of the current (not shown). Furthermore, Glibenclamide 
(10 /zM) inhibited this same effect, making it likely that 
the current elicited by KCOs in atrial myocytes is indeed 
due to the activation of KAX P channels. But, in contrast to 
results in guinea pig ventricular cells, where removal of 
ATP results in the activation of inwardly-rectifying chan- 
nels [7], in our experiments on atrial myocytes the current 
activated by KCOs displayed a pronounced outward-going 
rectification. As can easily be seen in Fig. 2B, Cromakalim 
in fact induced a huge outward current at potentials posi- 
tive to -50  mV, but did not modify the I /V  relationship 
at potentials negative to E K ( - 80 mV) to the same extent. 
Although the actual magnitude of the drug-sensitive out- 
ward current was found to vary among experiments, never- 
theless it always showed the same characteristic outward 
rectification. 
As for the action on the inward current, its voltage 
range of activation, between - 50 mV and - 30 mV, was 
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Fig. 2. Effect of Cromakalim on atrial myocytes. (A) Currents developing 
in response to voltage steps ranging from -60  to -110  mV, applied 
from a holding potential of -40  mV. (B) I /V  relationship obtained in 
response to a voltage ramp spanning from -110  to +40 mV from the 
same myocyte as in (A). Cromakalim (100/zM) induces a large increase 
in outward current and a marked reduction of an inward current. Gliben- 
clamide (10 ArM) almost completely reverses the increase of the outward 
current, while leaving totally unaffected the effect on the inward current. 
consistent with its being a background Na + current. In 
order to confirm this hypothesis, we used the Na channel 
blocker TTX. TTX, added at the concentration of 30 ~M 
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Fig. 3. TTX blocks the same inward current reduced by Cromakalim. (A) 
TTX (30 /zM) blocks the inward current. (B) Adding TTX (30 /zM) on 
top of Cromakalim (100 /xM) does not unveil any additional outward 
current, signifying that the KCO-induced ecrease of the inward current 
is not due to the overlapping of an outward current. (Data from a different 
cell than in (A)). 
to the superfusing control solution, totally eliminated this 
inward current (Fig. 3A). When TTX and Cromakalim 
were added together no outward shifts were visible over 
the -50  to -30  mV voltage range (Fig. 3B), consistent 
with the idea that the effect consisted in the block of an 
inward Na + current, rather than in the increase of an 
outward current. All the myocytes tested with TTX (n = 6) 
responded in the same fashion. 
The most striking finding presented in this paper is that 
two typical potassium channel openers, such as Cro- 
makalim and its active enantiomer Lemakalim, are able to 
inhibit a TTX-sensitive Na + current in atrial cardiomy- 
ocytes. They also act to increase a K ÷ conductance, but 
the two effects seem to be completely independent of each 
other. In fact, the KCOs-induced decrease of the Na ÷ 
current: (a) was detected in a higher percentage of experi- 
ments; this means that in some cases this effect could be 
seen in isolation from the one on the K ÷ current, and (b) 
was not blocked by Glibenclamide. Also, although this 
issue was not specifically addressed, we consistently ob- 
served a much faster onset of action of the drugs when 
decreasing the inward current han when inducing the K ÷ 
current. That KCOs, and KCO-related molecules may ex- 
ert effects on currents other than K + currents has been 
reported in recent papers, where they have been described 
mainly to decrease Ca 2+ currents [5,8]. So this is the first 
time, to our knowledge, that these benzopyrans are found 
to inhibit a Na ÷ current. 
It was surprising to find that both, Cromakalim and 
Lemakalim, were less likely to exert their prototypical 
effect, that of increasing a K + conductance. We do not 
have at present an explanation for this, so we can only 
offer a couple of hypotheses. (1) On the one hand, such a 
behavior may be in some way related to our experimental 
conditions. In fact, in our experiments the cells were 
studied in 'physiologic' conditions, with the superfusing 
solution containing lucose and the pipette solution includ- 
ing ATP. If it proved true that, as some authors have 
reported, these compounds are more active in ischemic 
conditions [8], then this could explain our finding (it must 
nevertheless be mentioned that a number of other experi- 
menters have employed experimental conditions imilar to 
ours and still described prominent KCO-induced activa- 
tions of K ÷ current). A necessary corollary to this hypoth- 
esis is that the ability of the compounds to interfere with 
Na ÷ channels would be unaffected by such differences in 
the metabolic state of the cells. (2) Alternatively, such a 
lower activity could reflect a species-related feature (the 
great majority of the studies on KCOs have been con- 
ducted in animal species other than rabbit). 
Whenever present, the drug-induced increase in the K ÷ 
conductance invariably appeared as the development of an 
outwardly rectifying current, so that at potentials negative 
to E K almost no changes were detected in the I /V  rela- 
tionship. This means that such current, once elicited, would 
not be expected to significantly affect the cell's resting 
potential; it would instead speed up the repolarization 
process, thus reducing the action potential duration. Actu- 
ally, shortening of the cardiac action potential has been the 
first documented effect of KCOs in the heart, to which the 
antiarrhythmic properties of these compounds, reported in 
many studies, have been attributed. In fact, although first 
introduced in therapy as antihypertensive agents, many 
different KCOs are at present being considered as potential 
antiarrhythmic compounds, but the results reported so far 
are still controversial: some studies have reported antiar- 
rhythmic actions, others have described arrhythmogenic 
and/or proarrhythmic properties (see Ref. [9]). In light of 
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this situation, our data on the effect of Cromakalim and 
Lemakalim on the TTX-sensitive Na + current could turn 
out to be useful in trying to understand the mechanism of 
action of these drugs. In fact, if this effect is confirmed in 
other experimental models, it could signify that KCOs may 
act to shorten the action potential through effects on K-- 
and Na + channels and thus decrease refractoriness. 
Through their action on Na ÷ channels they may also 
decrease the AP's amplitude and the velocity of conduc- 
tion, all actions likely to play an important role in the 
treatment of arrhythmias. 
The lack of effect of KCOs on the sino-atrial node cells 
is in agreement with those obtained by a previous investi- 
gator [5]. This could signify that either no KAT e, KCO- 
sensitive channels are present in this tissue, or that in 
experimental conditions mimicking physiologic settings 
these channels cannot be opened by these drugs. On the 
whole, the sino-atrial node seems less susceptible to the 
actions of KCOs than the atrium. Also, although such an 
issue has not yet been fully addressed, some preliminary 
data suggest a graded response to the compounds in the 
cells isolated from the node. Here, in fact, myocytes of the 
transitional type seem to respond to some extent to the 
application of Lemakalim. More experiments hould be 
performed in order to confirm these partial, but neverthe- 
less interesting, results. 
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